Home›Research›Compare›ARA-290 vs Humanin
Peptide ComparisonARA-290 vs Humanin
Both are Longevity & Cellular peptides.
ARA-290
Cibinetide
Half-life: ~2 min (IV); ~10–20 min (SC)
16 providers listed
Humanin
HN
Half-life: ~2-4 hours
9 providers listed
ARA-290 carries stronger published evidence (RCT, 3 key studies) than Humanin (Cohort study, 11); both are research compounds.
ARA-290
Evidence
Half-life
~2 min (IV); ~10–20 min (SC)
Humanin
Evidence
Half-life
~2-4 hours
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | ARA-290 |
| Further along in FDA review | ARA-290 |
| Less frequent dosing (longer half-life) | Humanin |
| More provider options (16 vs 9) | ARA-290 |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
ARA-290
Humanin
ARA-290
Immunometabolic dysregulation drives selective executive cognitive dysfunction in male db/db mice.
Cibinetide (ARA 290) reduces small nerve fiber pathology in sarcoidosis patients
ARA 290, a non-hematopoietic erythropoietin analogue, improves metabolic control and neuropathic symptoms in…
Humanin
Humanin and MOTS-c Attenuate Atrial Fibrillation by Suppressing Fibrosis and Mitochondrial Dysfunction.
Humanin Mitigates Aβ-Induced Retinal Pigment Epithelium Injury via AMPK-Beclin1-Dependent Mitophagy.
Humanin Restores Metabolic Hormone Homeostasis of Leptin, Ghrelin, Irisin and Asprosin in Streptozotocin-Indu…
Mitochondrial-derived Peptides and Cytoprotection in ARDS: Emerging Therapeutic Promise of Humanin.
+7 more
About ARA-290
Non-hematopoietic EPO analogue; activates innate repair receptor (IRR/EPOR/CD131 complex) without erythropoietic effects; promotes tissue repair and nerve healing
About Humanin
Mitochondria-derived peptide; binds gp130 receptor, activates STAT3/JAK pathway; inhibits BAX-mediated apoptosis; improves insulin sensitivity
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
ARA-290
No established clinical contraindications
Humanin
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
ARA-290
Humanin
Not enough vendor pricing yet.
Where to source these peptides
ARA-290
16 listed
Browse directory →
Providers offeringHumanin
9 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Longevity & Cellular Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated July 22, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). ARA-290 vs Humanin — Per-mg Price Comparison. Retrieved July 22, 2026, from https://peptidebase.io/peptides/compare/ara-290/humanin